ONO 7268MX1
Alternative Names: ONO-7268 MX1; Peptide-cocktail vaccine for hepatocellular carcinoma - OncoTherapy Science/Ono PharmaceuticalLatest Information Update: 17 May 2018
At a glance
- Originator OncoTherapy Science
- Developer Ono Pharmaceutical
- Class Cancer vaccines; Peptide vaccines; Peptides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Liver cancer
Most Recent Events
- 03 May 2018 Immunovaccine is now called IMV
- 28 Jul 2017 Discontinued - Phase-I for liver cancer in Japan (SC) (Ono Pharmaceutical pipeline, July 2017)
- 05 May 2016 Phase I development is ongoing in Japan